Randi R. Mathiesen
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials.
Journal: Molecular oncology
Published: February 14, 2024
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial.
Journal: Journal for immunotherapy of cancer
Published: December 27, 2023
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial.
Journal: Nature medicine
Published: October 17, 2022
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
Journal: Journal of the National Cancer Institute
Published: July 31, 2017
Cotargeting of CYP-19 (aromatase) and emerging, pivotal signalling pathways in metastatic breast cancer.
Journal: British journal of cancer
Published: August 10, 2016
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.
Journal: Genome biology
Published: July 25, 2016
Next-generation sequencing of disseminated tumor cells.
Journal: Frontiers in oncology
Published: October 30, 2013
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Journal: Breast cancer research : BCR
Published: April 19, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026